KLF5 and breast carcinoma: KLF5 is a zinc‐finger transcription factor highly expressed in several malignancies, which has recently become a popular target in cancer research.[36, 37, 38, 39] We also found that KLF5 small molecule inhibitor ML264 can effectively inhibit breast cancer metastasis, and it is expected to be used in the clinic in the future.